Stammen Alexander
Experienced Sales and Marketing Manager with proven people management skills and a demonstrated successful
history of working in the pharmaceuticals and medical devices industry. Strong track record in benchmark product
launches, marketing strategy development, translation into tactical planning, sales and people management in
high performing teams.
Specific areas of expertise in wound closure devices, hematology, oncology, infectious disease, CNS Mood
Disorders and immunology.
Geographical experience in local Benelux and regional EMEA markets.
Stammen Alexander
International Brand Director Inflammation RA Alfasigma
Thursday 23 May
Crack the Code on Omnichannel Execution
Omnichannel is a big topic in our industry, but today it seems that we get stuck in defining what it is, conversations on the latest tech and where we should go.
Thie focus on Strategy, Capability, Process and people is relevant, but we seem to forget that ‘execution’ is one of the biggest hurdles today in every BioPharma. That struggle to execute already happens at a very basic Multichannel level, let alone orchestrating an Omnichannel model.
This panel can bring forward interesting ideas, honest reflections and learnings from the field.
Executing Omnichannel is a key challenge for many organisations, they risk to get stuck in co-creating strategies, building capabilities and wainting for the perfect integration. Well, the best moment to start executing is yesterday, the next best moment is now.
- Why do we struggle with Omnichannel execution
- What is an execution capability
- How do you start executing: stories and learnings
- Scaling execution, is that even possible?
Moderator:
Philip Vyt
Founder
Shyfit
Panelists:
Rick Hollis
Customer and Business Excellence Director
Ipsen
Stammen Alexander
International Brand Director Inflammation RA
Alfasigma
Philippe Kirby
Global Head of Channel Engagement & Execution
MSD
